Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 456 followers
Latest posts
Last updated 10 days ago
Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Maapliv, amino acids, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Maapliv, amino acids, Status: Opinion
Human medicines European public assessment report (EPAR): Itovebi, inavolisib, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Itovebi, inavolisib, Status: Opinion
Human medicines European public assessment report (EPAR): Emtricitabine / Tenofovir alafenamide Viatris, emtricitabine,tenofovir alafenamide, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Emtricitabine / Tenofovir alafenamide Viatris...
Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status...
Human medicines European public assessment report (EPAR): Conexxence, denosumab, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Conexxence, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Aucatzyl, obecabtagene autoleucel, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Aucatzyl, obecabtagene autoleucel, Status: Opinion
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Status: Opinion
Human medicines European public assessment report (EPAR): Rolcya, denosumab, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Rolcya, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Status: Opinion
10 days ago
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Status: Opinion
Human medicines European public assessment report (EPAR): Riulvy, tegomil fumarate, Status: Opinion under re-examination
10 days ago
Human medicines European public assessment report (EPAR): Riulvy, tegomil fumarate, Status: Opinion...
Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion
about 1 month ago
Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion